LISATA THERAPEUTICS, INC. (LSTA)

Every figure this model derived for LSTA, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2026-06-30
cash 10,443,559 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 11,013,000 AssetsCurrent 2026-06-30
current liabilities 2,987,000 LiabilitiesCurrent 2026-06-30
equity 8,244,000 StockholdersEquity 2026-06-30
ocf -12,323,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 100,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 1,035,000 AllocatedShareBasedCompensationExpense 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up LSTA on one particular measure came for.

RatioValue
current ratio3.69
current ratio reported3.69
deferred revenue growth5.6
dilution pct4.3
revenue growth-90.65
revenue growth per share-91.04
rule of 40-16517.65
sbc pct revenue1035.0

What to be careful about

What this model itself distrusts about LSTA's figures. Written by the derivation as it ran, not added afterwards.